share_log

信达证券4月10日发布研报称，给予可孚医疗（301087.SZ）买入评级。评级理由主要包括：1）聚焦核心品类，“自主品牌+代理”产品组合出击，五大业务线齐头并进，驱动成长；2）“线上”+“线下”渠道双管齐下，自产率不断提升，增强盈利能力。（每日经济新闻）

Cinda Securities released a research report on April 10 stating that it gave Corfu Healthcare (301087.SZ) a purchase rating. The main reasons for the rating include: 1) focusing on core categories, the “independent brand+agency” product portfolio, and the

Zhitong Finance ·  Apr 10 15:29
Cinda Securities released a research report on April 10 stating that it gave Corfu Healthcare (301087.SZ) a purchase rating. The main reasons for the rating include: 1) focusing on core categories, the “independent brand+agency” product portfolio, and the five major business lines working hand in hand to drive growth; 2) “online” + “offline” channels go hand in hand to drive growth; 2) the self-production rate continues to increase and enhance profitability. (Mainichi Keizai Shimbun)

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment